The Spectranetics Corporation (Spectranetics) develops, manufactures, markets and distributes single-use medical devices used in minimally invasive procedures within the cardiovascular system for use with Spectranetics' excimer laser system. The Company’s laser system includes the CVX-300 laser unit and various disposable fiber-optic laser catheters. Its laser catheters contain up to 250 small diameter, flexible optical fibers that can access difficult to reach peripheral and coronary anatomy and produce evenly distributed laser energy at the tip of the catheter for uniform ablation. The Company’s products are focused on two categories: vascular intervention and cardiac lead removal. As of December 31, 2008, the Company’s installed base of laser systems was 850, of which 627were in the United States. On May 30, 2008, Spectranetics acquired the endovascular business of Kensey Nash Corporation (KNC).